Surrozen Inc (NAS:SRZN)
$ 9.85 -1.1399 (-10.37%) Market Cap: 31.51 Mil Enterprise Value: 7.00 Mil PE Ratio: 0 PB Ratio: 0.69 GF Score: 19/100

Q4 2022 Surrozen Inc Earnings Call Transcript

Mar 22, 2023 / 08:30PM GMT
Release Date Price: $14.89 (-3.64%)
Operator

Good afternoon, and welcome to the Surrozen Corporate Update Conference Call. My name is Josh, and I will be your manager for this call. I will now turn the call over to Craig Parker, CEO of Surrozen to begin the call.

Craig C. Parker
Surrozen, Inc. - CEO, President & Director

Thanks, Josh, and thank all of you for joining us today for this important corporate update. As Josh said, I'm Craig Parker, CEO of Surrozen. And with me today is Chuck Williams, the Chief Financial Officer at Surrozen. We'll be providing corporate and R&D pipeline updates today and will then address questions.

Slide 2. I'll be making forward-looking statements. Please consult our SEC filings, in particular, our 2022 annual report on Form 10-K for a full discussion of our risk factors.

Slide 3. As some of you know, Surrozen is the preeminent innovator in using the Wnt pathway, the body's own physiologic mechanism for tissue repair to selectively stimulate tissue regeneration in a broad range of diseases. We do this through our proprietary platform and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot